Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Summary of prospective clinical studies evaluating efficacy of lenalidomide in the management of chronic lymphocytic leukemia (CLL).
| Study | Phase | Patient population | Treatment | ORR (%) | PFS |
|---|---|---|---|---|---|
| Chanan-Khan et al. [2006] | II | Relapsed/Refractory CLL | Lenalidomide (N = 45, evaluable for response = 29) | 47 | NR |
| Ferrajoli et al. [2008] | II | Relapsed/Refractory CLL | Lenalidomide (N = 44) | 32 | NR |
ORR, overall response rate; PFS, progression-free survival; NR, not reported.
